Mr. Andrew D. C. LaFrence, also known as Andy, CPA, has been the Chief Financial Officer and Principal Accounting Officer of Surmodics, Inc. since February 12, 2013 and November 30, 2016 respectively and has been its Vice President of Finance and Information Systems since September 20, 2016. Mr. LaFrence served as a Vice President of Finance at Surnodics, Inc. since February 12, 2013 until September 20, 2016. Mr. LaFrence served as the Chief Financial Officer at CNS Therapeutics, Inc. He has over 25 years of financial and management experience. He was an Audit Partner at KPMG LLP (Formerly KPMG Inc.), where he focused on supporting venture backed, high growth medical technology, pharmaceutical, biotech and clean tech private and public companies. He spent 26 years with KPMG. He has been a Director of Biothera, Inc., since August 29, 2011. He serves as a Director of Biothera Holding Corp., He served as Director of LifeScience Alley. Mr. LaFrence is a certified public accountant and has a B.S. in accounting and a minor in Business Administration from the Illinois State University.